This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore practical zero based budgeting tips for two-income households to coordinate spending, manage shared goals, and promote savings.
23,842 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
European stocks slump as Middle East tensions lift rate expectations for the ECB and BoE, signaling a new Atlantic ri...
Tech ETFs split into three paths in 2026: broad mega-cap funds stumble, cybersecurity themes gain ground, and AI infr...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
Authorities arrest missing suspect in the Ledger co-founder kidnapping, marking a major breakthrough after weeks of p...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Bitcoin is notoriously volatile, but history shows recurring recovery patterns after big crashes. This article explai...
Ethereum sits just above $2,100 as on-chain data shows exchange reserves shrinking to levels not seen since 2016, wit...
With the CLARITY Act stalled in the Senate, XRP traders await a potential reset. A clearance could alter liquidity an...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
NVIDIA’s shares hover near $198 as investors weigh whether the AI leader’s growth justifies a premium. The stock now ...
AI-driven infrastructure growth is lifting semiconductor ETFs and a broad set of chipmakers. The wave is broadening b...